1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Tumor Ablation Devices Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Tumor Ablation Devices by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Tumor Ablation Devices by Country/Region, 2020, 2024 & 2031
2.2 Tumor Ablation Devices Segment by Type
2.2.1 Microwave Ablation
2.2.2 Laser Ablation
2.2.3 Ultrasound Ablation
2.3 Tumor Ablation Devices Sales by Type
2.3.1 Global Tumor Ablation Devices Sales Market Share by Type (2020-2025)
2.3.2 Global Tumor Ablation Devices Revenue and Market Share by Type (2020-2025)
2.3.3 Global Tumor Ablation Devices Sale Price by Type (2020-2025)
2.4 Tumor Ablation Devices Segment by Application
2.4.1 Urological Surgery
2.4.2 Gynecological Surgery
2.4.3 General Surgery
2.4.4 Gastrointestinal Surgery
2.4.5 Others
2.5 Tumor Ablation Devices Sales by Application
2.5.1 Global Tumor Ablation Devices Sale Market Share by Application (2020-2025)
2.5.2 Global Tumor Ablation Devices Revenue and Market Share by Application (2020-2025)
2.5.3 Global Tumor Ablation Devices Sale Price by Application (2020-2025)
3 Global Tumor Ablation Devices by Company
3.1 Global Tumor Ablation Devices Breakdown Data by Company
3.1.1 Global Tumor Ablation Devices Annual Sales by Company (2020-2025)
3.1.2 Global Tumor Ablation Devices Sales Market Share by Company (2020-2025)
3.2 Global Tumor Ablation Devices Annual Revenue by Company (2020-2025)
3.2.1 Global Tumor Ablation Devices Revenue by Company (2020-2025)
3.2.2 Global Tumor Ablation Devices Revenue Market Share by Company (2020-2025)
3.3 Global Tumor Ablation Devices Sale Price by Company
3.4 Key Manufacturers Tumor Ablation Devices Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Tumor Ablation Devices Product Location Distribution
3.4.2 Players Tumor Ablation Devices Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2025)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Tumor Ablation Devices by Geographic Region
4.1 World Historic Tumor Ablation Devices Market Size by Geographic Region (2020-2025)
4.1.1 Global Tumor Ablation Devices Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Tumor Ablation Devices Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Tumor Ablation Devices Market Size by Country/Region (2020-2025)
4.2.1 Global Tumor Ablation Devices Annual Sales by Country/Region (2020-2025)
4.2.2 Global Tumor Ablation Devices Annual Revenue by Country/Region (2020-2025)
4.3 Americas Tumor Ablation Devices Sales Growth
4.4 APAC Tumor Ablation Devices Sales Growth
4.5 Europe Tumor Ablation Devices Sales Growth
4.6 Middle East & Africa Tumor Ablation Devices Sales Growth
5 Americas
5.1 Americas Tumor Ablation Devices Sales by Country
5.1.1 Americas Tumor Ablation Devices Sales by Country (2020-2025)
5.1.2 Americas Tumor Ablation Devices Revenue by Country (2020-2025)
5.2 Americas Tumor Ablation Devices Sales by Type
5.3 Americas Tumor Ablation Devices Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Tumor Ablation Devices Sales by Region
6.1.1 APAC Tumor Ablation Devices Sales by Region (2020-2025)
6.1.2 APAC Tumor Ablation Devices Revenue by Region (2020-2025)
6.2 APAC Tumor Ablation Devices Sales by Type
6.3 APAC Tumor Ablation Devices Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Tumor Ablation Devices by Country
7.1.1 Europe Tumor Ablation Devices Sales by Country (2020-2025)
7.1.2 Europe Tumor Ablation Devices Revenue by Country (2020-2025)
7.2 Europe Tumor Ablation Devices Sales by Type
7.3 Europe Tumor Ablation Devices Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Tumor Ablation Devices by Country
8.1.1 Middle East & Africa Tumor Ablation Devices Sales by Country (2020-2025)
8.1.2 Middle East & Africa Tumor Ablation Devices Revenue by Country (2020-2025)
8.2 Middle East & Africa Tumor Ablation Devices Sales by Type
8.3 Middle East & Africa Tumor Ablation Devices Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Tumor Ablation Devices
10.3 Manufacturing Process Analysis of Tumor Ablation Devices
10.4 Industry Chain Structure of Tumor Ablation Devices
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Tumor Ablation Devices Distributors
11.3 Tumor Ablation Devices Customer
12 World Forecast Review for Tumor Ablation Devices by Geographic Region
12.1 Global Tumor Ablation Devices Market Size Forecast by Region
12.1.1 Global Tumor Ablation Devices Forecast by Region (2026-2031)
12.1.2 Global Tumor Ablation Devices Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Tumor Ablation Devices Forecast by Type
12.7 Global Tumor Ablation Devices Forecast by Application
13 Key Players Analysis
13.1 Ethicon
13.1.1 Ethicon Company Information
13.1.2 Ethicon Tumor Ablation Devices Product Portfolios and Specifications
13.1.3 Ethicon Tumor Ablation Devices Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Ethicon Main Business Overview
13.1.5 Ethicon Latest Developments
13.2 Karl Storz
13.2.1 Karl Storz Company Information
13.2.2 Karl Storz Tumor Ablation Devices Product Portfolios and Specifications
13.2.3 Karl Storz Tumor Ablation Devices Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Karl Storz Main Business Overview
13.2.5 Karl Storz Latest Developments
13.3 Intuitive Surgical
13.3.1 Intuitive Surgical Company Information
13.3.2 Intuitive Surgical Tumor Ablation Devices Product Portfolios and Specifications
13.3.3 Intuitive Surgical Tumor Ablation Devices Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Intuitive Surgical Main Business Overview
13.3.5 Intuitive Surgical Latest Developments
13.4 Medtronic
13.4.1 Medtronic Company Information
13.4.2 Medtronic Tumor Ablation Devices Product Portfolios and Specifications
13.4.3 Medtronic Tumor Ablation Devices Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Medtronic Main Business Overview
13.4.5 Medtronic Latest Developments
13.5 Olympus
13.5.1 Olympus Company Information
13.5.2 Olympus Tumor Ablation Devices Product Portfolios and Specifications
13.5.3 Olympus Tumor Ablation Devices Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Olympus Main Business Overview
13.5.5 Olympus Latest Developments
13.6 Aesculap
13.6.1 Aesculap Company Information
13.6.2 Aesculap Tumor Ablation Devices Product Portfolios and Specifications
13.6.3 Aesculap Tumor Ablation Devices Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Aesculap Main Business Overview
13.6.5 Aesculap Latest Developments
13.7 Applied Medical
13.7.1 Applied Medical Company Information
13.7.2 Applied Medical Tumor Ablation Devices Product Portfolios and Specifications
13.7.3 Applied Medical Tumor Ablation Devices Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Applied Medical Main Business Overview
13.7.5 Applied Medical Latest Developments
13.8 B. Braun Melsungen
13.8.1 B. Braun Melsungen Company Information
13.8.2 B. Braun Melsungen Tumor Ablation Devices Product Portfolios and Specifications
13.8.3 B. Braun Melsungen Tumor Ablation Devices Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 B. Braun Melsungen Main Business Overview
13.8.5 B. Braun Melsungen Latest Developments
13.9 CareFusion
13.9.1 CareFusion Company Information
13.9.2 CareFusion Tumor Ablation Devices Product Portfolios and Specifications
13.9.3 CareFusion Tumor Ablation Devices Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 CareFusion Main Business Overview
13.9.5 CareFusion Latest Developments
13.10 Conmed
13.10.1 Conmed Company Information
13.10.2 Conmed Tumor Ablation Devices Product Portfolios and Specifications
13.10.3 Conmed Tumor Ablation Devices Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Conmed Main Business Overview
13.10.5 Conmed Latest Developments
13.11 Davol
13.11.1 Davol Company Information
13.11.2 Davol Tumor Ablation Devices Product Portfolios and Specifications
13.11.3 Davol Tumor Ablation Devices Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Davol Main Business Overview
13.11.5 Davol Latest Developments
13.12 Encision
13.12.1 Encision Company Information
13.12.2 Encision Tumor Ablation Devices Product Portfolios and Specifications
13.12.3 Encision Tumor Ablation Devices Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Encision Main Business Overview
13.12.5 Encision Latest Developments
13.13 Eon Surgical
13.13.1 Eon Surgical Company Information
13.13.2 Eon Surgical Tumor Ablation Devices Product Portfolios and Specifications
13.13.3 Eon Surgical Tumor Ablation Devices Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Eon Surgical Main Business Overview
13.13.5 Eon Surgical Latest Developments
13.14 Gyrus ACMI
13.14.1 Gyrus ACMI Company Information
13.14.2 Gyrus ACMI Tumor Ablation Devices Product Portfolios and Specifications
13.14.3 Gyrus ACMI Tumor Ablation Devices Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 Gyrus ACMI Main Business Overview
13.14.5 Gyrus ACMI Latest Developments
13.15 Integra LifeSciences
13.15.1 Integra LifeSciences Company Information
13.15.2 Integra LifeSciences Tumor Ablation Devices Product Portfolios and Specifications
13.15.3 Integra LifeSciences Tumor Ablation Devices Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 Integra LifeSciences Main Business Overview
13.15.5 Integra LifeSciences Latest Developments
13.16 IMRIS
13.16.1 IMRIS Company Information
13.16.2 IMRIS Tumor Ablation Devices Product Portfolios and Specifications
13.16.3 IMRIS Tumor Ablation Devices Sales, Revenue, Price and Gross Margin (2020-2025)
13.16.4 IMRIS Main Business Overview
13.16.5 IMRIS Latest Developments
14 Research Findings and Conclusion
※参考情報 腫瘍切除装置は、がん細胞を除去または破壊するために使用される医療機器の一種です。これらの装置は、腫瘍の位置や大きさ、種類、そして患者の全体的な健康状態に応じて異なる方法で機能します。腫瘍切除装置は、がん治療において重要な役割を果たしており、放射線療法や化学療法といった他の治療法と併用されることが一般的です。 腫瘍切除装置の特徴の一つは、侵襲性の少ない手法で腫瘍を治療できる点です。従来の外科手術では、腫瘍を切除するために大きな切開が必要でしたが、腫瘍切除装置はより小さな切開や、あるいは皮膚を切開せずに行うことができる技術も発展しています。このような技術により、患者の回復時間が短縮され、痛みや出血のリスクが低減されることが期待されます。 腫瘍切除装置の種類は多岐にわたりますが、一般的には以下のような技術が主に利用されています。まず、ラジオ波焼灼療法(Radiofrequency Ablation: RFA)があります。この方法は、特定の周波数の電波を利用して腫瘍細胞を高温にし、熱によって細胞を破壊する技術です。RFAは、主に肝臓や腎臓に発生する腫瘍に対して有効であり、比較的簡単に実施できるため、多くの医療機関で普及しています。 次に、マイクロ波焼灼療法(Microwave Ablation: MWA)もあります。これは、マイクロ波を使用して腫瘍細胞を加熱し、焼灼する方法です。RFAと異なり、MWAはより深い組織にも効果を発揮することができ、多様なサイズや位置の腫瘍に対応可能です。特に肝臓や肺の腫瘍に対して有用性が高いとされています。 さらに、冷凍療法(Cryoablation)も腫瘍切除の手法として知られています。冷凍療法は、腫瘍細胞を非常に低温に冷却することで、それを破壊する方法であり、特に皮膚や腎臓の腫瘍に対して適用されることが多いです。冷凍療法は、傷害を受けた周囲の組織に対する影響が少なく、回復が早いという利点があります。 加えて、化学療法を用いた腫瘍切除も一部の症例では考慮されることがあります。特に、動脈塞栓療法(Transarterial Chemoembolization: TACE)は、特定の血管から腫瘍に対して薬剤を直接投与する手法であり、腫瘍の血液供給を遮断することで腫瘍の成長を抑制することを目的としています。この方法も、肝臓の腫瘍治療において非常に一般的です。 腫瘍切除装置の用途は主にがん治療ですが、良性腫瘍の治療やその他の病状にも応用されることがあります。また、臨床研究が進む中で、新しい技術や手法が開発されており、それにより腫瘍治療の選択肢が広がっていくことが期待されています。 関連技術に関しても、画像診断技術の向上が腫瘍切除装置の効果を高めています。CTスキャンやMRI、超音波検査などの画像診断技術は、腫瘍の正確な位置とサイズを把握し、腫瘍切除装置を効果的に利用するために必要不可欠です。これらの診断技術と併用することで、より高精度な治療が実現され、患者の生存率向上に寄与しています。 さらに、ロボット手術技術の進歩も見逃せません。ロボット支援手術では、外科医が高精度な操作を行えるため、ダメージを最小限に抑えた腫瘍切除が可能となります。この技術は特に複雑な症例において非常に有用であり、今後の腫瘍治療の発展に寄与することが期待されます。 腫瘍切除装置は、今後もますます進化し続ける分野であり、より多くの患者に安全で効果的な治療を提供するための研究が続けられています。患者の負担を軽減し、治療成績を向上させるために、新しい技術や手法の開発が期待される中で、医療界全体がこの領域に注目しています。 以上のように、腫瘍切除装置はがん治療において重要な役割を果たしており、その技術は日々進歩しています。患者一人一人に最適な治療法が提供されるよう、今後の技術的発展が待たれるところです。希望の持てる治療法として、腫瘍切除装置は多くの患者の治癒への道を照らす存在であり続けるでしょう。 |
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/